Amarin Corporation (AMRN)
AMRN · BiotechSign PipelinePipeline Overview
- Therapeutic Focus
- Cardiovascularsrc
Signal Snapshot
0
Clinical Trials (ClinicalTrials.gov aggregate)
0
Catalyst Records
5
Publications on Record
ClinicalTrials.gov aggregate as of 2026-09-29. Source
Recent Publications
- Global, regional, and national prevalence of second-hand smoke and attributable disease burden in 204 countries and territories, 1990-2023: a systematic analysis for the Global Burden of Disease Study 2023. — Lancet Public Health (2026) PMID 42705247
- Global, Regional, and National Burden of Myocarditis and Its Impairment, 1990-2023. — J Am Coll Cardiol (2026) PMID 42684212
5 total publications tracked — view all on BiotechSign
Get real-time catalyst alerts, analyst signals, dilution risk scores, and full pipeline data for Amarin Corporation.
Full AMRN Data Sign Up FreePrimary Sources
This page reports only records present in the BiotechSign source payload as of the generation date. It does not infer drug efficacy, clinical outcome probability, approval odds, revenue, market size, or unreported regulatory events.